IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ARICI, Bruna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.943
NA - Nord America 1.568
AS - Asia 835
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AF - Africa 6
SA - Sud America 4
Totale 4.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.545
DE - Germania 599
CN - Cina 410
PL - Polonia 338
UA - Ucraina 337
IT - Italia 179
SG - Singapore 163
FI - Finlandia 126
RU - Federazione Russa 97
IN - India 93
GB - Regno Unito 77
HK - Hong Kong 72
FR - Francia 70
TR - Turchia 58
IE - Irlanda 50
SE - Svezia 30
CA - Canada 21
BE - Belgio 19
VN - Vietnam 14
EU - Europa 13
AU - Australia 7
ID - Indonesia 6
IR - Iran 5
NL - Olanda 5
CZ - Repubblica Ceca 4
TH - Thailandia 4
MU - Mauritius 3
BD - Bangladesh 2
BG - Bulgaria 2
ES - Italia 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
CL - Cile 1
JP - Giappone 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 4.377
Salva come PNG Salva come JPEG
Città #
Warsaw 338
Jacksonville 239
Singapore 129
Chandler 115
Fairfield 114
Woodbridge 105
Ashburn 103
Ann Arbor 102
Princeton 96
Nanjing 95
Wilmington 81
Helsinki 79
Beijing 73
Hong Kong 70
Houston 68
New York 64
Cambridge 62
Dearborn 49
Dublin 49
Istanbul 44
Seattle 40
Nanchang 35
Brescia 32
Shenyang 27
Hebei 22
Tianjin 22
Changsha 21
Jinan 20
Des Moines 18
Brussels 17
Jiaxing 15
Milan 15
Moscow 14
Munich 13
Pune 13
Dong Ket 12
Lancaster 12
Kocaeli 11
Kunming 11
Toronto 11
Hangzhou 10
Shanghai 10
Falkenstein 9
North York 9
Nürnberg 9
San Diego 8
San Francisco 8
Verona 8
Ningbo 7
Boardman 5
Guangzhou 5
Haikou 5
Jakarta 5
Los Angeles 5
Taizhou 5
Zhengzhou 5
Melbourne 4
Napoli 4
Borås 3
Castelnuovo Bozzente 3
Hefei 3
Lanzhou 3
Norwalk 3
Orange 3
Phoenix 3
Rome 3
Treviglio 3
Amsterdam 2
Augusta 2
Berlin 2
Brno 2
Catanzaro 2
Colliano 2
Copertino 2
Duncan 2
Ferrara 2
Fuzhou 2
Gardone Riviera 2
Lappeenranta 2
Lecco 2
London 2
Parma 2
Perugia 2
Romola 2
Santa Caterina Dello Ionio 2
Sofia 2
Sydney 2
Acireale 1
Almaty 1
Astana 1
Bangkok 1
Barlassina 1
Belpasso 1
Borgo Di Terzo 1
Bras 1
Bratislava 1
Brooklyn 1
Bryansk 1
Canberra 1
Carpi 1
Totale 2.657
Salva come PNG Salva come JPEG
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 283
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 220
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 190
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 168
Preparazione di colture primarie di fibroblasti di embrione di pollo . 151
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 139
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 133
microRNAs and human hepatocellular carcinoma 129
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 120
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 116
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 116
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 109
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 107
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 104
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 101
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 90
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 89
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 85
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 83
Urokinase and c-met are target of miR-23b in human cells. 79
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 78
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 77
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 74
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 73
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 72
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 72
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 71
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 69
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 69
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 68
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 68
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 68
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 67
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 66
RNA interference for urokinase gene in human hepatocellular carcinoma 66
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 65
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 64
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 64
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 63
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 63
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 62
Tecniche di conservazione delle cellule mediante congelamento. 59
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 58
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 58
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 57
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 56
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 55
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 54
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 22
Totale 4.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020684 0 0 0 0 0 124 116 114 51 157 63 59
2020/2021591 14 76 13 66 15 68 19 81 109 55 54 21
2021/2022356 9 66 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024361 20 12 28 10 26 90 36 7 72 6 4 50
2024/2025339 2 19 4 117 83 114 0 0 0 0 0 0
Totale 4.470